SEATTLE, April 2 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) will
release first quarter 2001 earnings on Wednesday, April 18, 2001, after the
close of U.S. financial markets. This announcement will be made available on
the Immunex website at http://www.immunex.com, and on PRNewswire's website at
http://www.prnewswire.com.
Additionally, Immunex executives will host a conference call and live
audio webcast at 2:00 p.m. PDT (5:00 p.m. EDT) on April 18th to discuss the
company's financial results. The live webcast can be accessed on the Immunex
website at http://www.immunex.com/investor_fs3.html. Replay of the live
webcast will also be made available on the Immunex website by clicking
"Investor Relations/Events/Webcasts" shortly after the conclusion of the call
and will be available through April 25, 2001.
Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.
NOTE: Except for the historical information contained herein, this news
release contains forward-looking statements that involve substantial risks and
uncertainties. Among the factors that could cause actual results or timelines
to differ materially are risks associated with research and clinical
development, regulatory approvals, our supply capabilities and reliance on
third-party manufacturers, product commercialization, competition, litigation
and other risk factors listed from time to time in reports filed by Immunex
with the SEC, including but not limited to risks described under the caption
"Important Factors That May Affect Our Business, Our Results of Operations
and Our Stock Price" within our most recently filed Form 10-K. The
forward-looking statements contained in this news release represent our
judgment as of the date of this release. Immunex undertakes no obligation
to publicly update any forward-looking statements.
SOURCE Immunex Corporation
 back to top
Related links:
http://www.immunex.com
Company News On-Call:
http://www.prnewswire.com/comp/434644.html or fax,
800-758-5804, ext. 434644
CONTACT:
Media, Robin Shapiro, 206-389-4040, or
Investors, Mark Leahy, 206-389-4363, both of Immunex Corporation
|
